Malignant astrocytic tumors: Clinical importance of apparent diffusion coefficient in prediction of grade and prognosis

Radiology

Volumn 241, Issue 3, 2006, Pages 839-846

  Higano, Shuichi ^a   Yun, Xia ^a   Kumabe, Toshihiro ^a   Watanabe, Mika ^b   Mugikura, Shunji ^a   Umetsu, Atsushi ^a   Sato, Akihiro ^a   Yamada, Takayuki ^a   Takahashi, Shoki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GADODIAMIDE; GADOLINIUM PENTETATE; KI 67 ANTIGEN; NIMUSTINE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN RADIATION; BRAIN TUMOR; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOLOGY; MALE; MONOTHERAPY; NEUROIMAGING; NEURONAVIGATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; THREE DIMENSIONAL IMAGING;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KI-67 ANTIGEN; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 33846700422     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2413051276     Document Type: Article

References (21)

1. Kleihues P, Cavenee WK. World Health Organization classification of tumours: pathology and genetics of tumours of the central nervous system. Lyon, France: International Agency for Research on Cancer, 2000.
2. Saleman M. Glioblastoma multiforme and anaplastic astrocytoma. In: Kaye AH, Law ER Jr, eds. Brain tumors: an encyclopedic approach. 2nd ed. London, England: Churchill Livingstone, 2001.
3. Kiss R, Dewitte O, Decaestecker C, et al. The combined determination of proliferative activity and cell density in the prognosis of adult patients with supratentorial high-grade astrocytic tumors. Am J Clin Pathol 1997;107(3):321-331.
4. Torp SH, Granli US. Proliferative activity in human glioblastomas assessed by various techniques. APMIS 2001;109(12):865-869.
5. Torp SM. Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies. Clin Neuropathol 2002;21(6):252-257.
6. Neder L, Colli BO, Machado HR, Carlotti CG Jr, Santos AC, Chimelli L. MIB-1 labeling index in astrocytic tumors: a clinicopathologic study. Clin Neuropathol 2004;23(6):262-270.
7. Gupta RK, Cloughesy TF, Sinha U, et al. Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 2000;50(3):215-226.
8. Gupta RK, Sinha U, Cloughesy TF, Alger JR. Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma. Magn Reson Med 1999;41(1):2-7.
9. Bulakbasi N, Guvenc I, Onguru O, Erdogan E, Tayfun C, Ucoz T. The added value of the apparent diffusion coefficient calculation to magnetic resonance imaging in the differentiation and grading of malignant brain tumors. J Comput Assist Tomogr 2004;28(6):735-746.
10. Bulakbasi N, Kocaoglu M, Ors F, Tayfun C, Ucoz T. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. AJNR Am J Neuroradiol 2003;24(2):225-233.
11. Gauvain KM, McKinstry RC, Mukherjee P, et al. Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR Am J Roentgenol 2001;177(2):449-454.
12. Lam WW, Poon WS, Metreweli C. Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma? Clin Radiol 2002;57(3):219-225.
13. Muti M, Aprile I, Principi M, et al. Study on the variations of the apparent diffusion coefficient in areas of solid tumor in high grade gliomas. Magn Reson Imaging 2002;20(9):635-641.
14. Sugahara T, Korogi Y, Kochi M, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9(1):53-60.
15. Guo AC, Cummings TJ, Dash RC, Provenzale JM. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002;224(1):177-183.
16. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5(6):649-655.
17. Calvar JA, Meli FJ, Romero C, al. Characterization of brain tumors by MRS, DWI and Ki-67 labeling index. J Neurooncol 2005;72(3):273-280.
18. Tamiya T, Kinoshha K, Ono Y, Matsumoto K, Furuta T, Ohmoto T. Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology 2000;42(5):333-338.
19. Oh J, Henry RG, Pirzkall A, et al. Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging 2004;19(5):546-554.
20. Aprile I, Muti M, Principi M, et al. A magnetic resonance comparative study between enhancement, rCBV and ADC in brain glioblastomas. Radiol Med (Torino) 2002;104(1-2):87-91.
21. Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 2002;44(8):656-666.